Forget UnitedHealth: Two Stocks to Buy Now for 2026
Regulatory pressure around UnitedHealth shifts attention to two defensible, cash-generating stocks with strong divide...
This piece explains what sequence of returns risk is in retirement, why it matters for retirement income, and how to interpret its effects on portfolios.
26,990 articlesRegulatory pressure around UnitedHealth shifts attention to two defensible, cash-generating stocks with strong divide...
Investors are quietly shifting capital away from high-velocity AI bets and toward steady cash-flow leaders. Discover ...
March is on the horizon, and I’m paying close attention to IBM as it heads into a new earnings cycle. The century-old...
A family debates paying elderly parents $1,000 a month for babysitting, but opts to fund an investment for the parent...
A century of uninterrupted payouts makes this historic dividend stock hand a rare anchor for investors navigating vol...
A notable stake by Starboard Value in Fluor hints at renewed confidence in the industrial cycle. This article explain...
A disciplined $100/month Bitcoin plan started in 2015 would have yielded about $632,000 by May 2026, according to Coi...
Meta Platforms is pouring billions into AI infrastructure. This piece breaks down why that spending could pay off for...
A small-cap value ETF built years of academic research is beating the S&P 500 in early 2026, buoyed by a strict value...
Thinking beyond quick wins, this guide shows how to build a reliable, growing income stream over two decades. Meet th...
SpaceX's massive debt offering sent a chill through space-focused equities as Virgin Galactic and Rocket Lab swayed o...
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...